Related Experiment Videos
Role of blood pressure in the development of congestive heart failure. The Framingham study
The New England Journal of Medicine
|October 19, 1972
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Mortality surveillance system: the first models from year.
Vital and health statistics. Series 20, Data from the National Vital Statistics System·2014
Mortality surveillance system: models from the second year.
Vital and health statistics. Series 20, Data from the National Vital Statistics System·2014
Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin.
Journal of thrombosis and haemostasis : JTH·2011
Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation.
Journal of thrombosis and haemostasis : JTH·2008
Brian MacMahon (1923-2007): founder of modern epidemiology.
Cancer causes & control : CCC·2008
Tarlatamab-Durvalumab Maintenance for Extensive-Stage Small-Cell Lung Cancer.
The New England journal of medicine·2026
Sacituzumab Tirumotecan plus Pembrolizumab in PD-L1-Negative Advanced NSCLC.
The New England journal of medicine·2026
Osimertinib-Savolitinib in Advanced NSCLC after Progression during EGFR-TKI Therapy.
The New England journal of medicine·2026
Durvalumab, Tremelimumab, and Enfortumab Vedotin in Muscle-Invasive Bladder Cancer.
The New England journal of medicine·2026
Anbenitamab plus HB1801 for HER2-Positive Advanced Breast Cancer.
The New England journal of medicine·2026
Divarasib as Compared with Sotorasib or Adagrasib in KRAS G12C-Mutated NSCLC.
The New England journal of medicine·2026
A Multielement Ionomic Dysregulation Pattern Is Associated with NT-proBNP and Cardiorenal Burden in Patients with Cardiovascular Disease.
Molecules (Basel, Switzerland)·2026
Combination Therapy Potential of HTD1801 (Berberine Ursodeoxycholate) in MASLD/MASH and Cardiovascular-Kidney-Metabolic Disease: A Narrative Review.
Pharmaceuticals (Basel, Switzerland)·2026
Cardiovascular Diseases and Type 2 Diabetes: 2nd Edition.
Medicina (Kaunas, Lithuania)·2026